Skip to Content

Join the 'Herpes Zoster' group to help and get support from people like you.

Herpes Zoster News

Related terms: Shingles

There's a New Shingles Vaccine, Shingrix, -- Is It for You?

Posted 26 Oct 2017 by Drugs.com

THURSDAY, Oct. 26, 2017 – On the heels of approval of a better vaccine for the painful condition shingles, adults over 50 should plan to roll up their sleeves – again. The new vaccine, Shingrix, will likely be recommended even for those already inoculated with an older vaccine. An advisory panel of the U.S. Centers for Disease Control and Prevention recommended Wednesday that all adults 50 and older receive the new two-shot vaccine, just days after the U.S. Food and Drug Administration announced its approval of Shingrix. Shingrix, manufactured by GlaxoSmithKline, is more than 90 percent effective in preventing shingles, a painful skin disease that afflicts about one of every three people in the United States during their lifetime. If the CDC adopts the panel's recommendation, Shingrix will supplant the only other shingles vaccine available, the single-dose Merck product Zostavax. "The ... Read more

Related support groups: Herpes Zoster, Zostavax, Varicella-Zoster, Herpes Zoster Otitis Externa, Shingrix, Herpes Zoster Iridocyclitis, Herpes Zoster Myelitis, Herpes Zoster Peripheral Neuropathy, Herpes Zoster Meningitis

Expert Panel Recommends New Shingles Vaccine, Shingrix, as First-Line Treatment

Posted 26 Oct 2017 by Drugs.com

A new shingles vaccine that provides far more protection than its predecessor received the full blessing of a U.S. government vaccine advisory panel on Wednesday. In a close 8-7 vote, the Advisory Committee on Immunization Practices recommended that Shingrix be chosen over Zostavax as the shingles vaccine of choice in adults aged 50 and older, the Washington Post reported. Previously, a shingles vaccine had only been recommended for those aged 60 and older. The panel went even further, and recommended that anyone who has been vaccinated with the Zostavax vaccine be re-vaccinated with the Shingrix vaccine – that group numbers about 20 million people, the Post reported. In total, more than 40 million people will be affected by the new recommendations, the newspaper said. Shingles is an extraordinarily painful rash caused by the chickenpox virus. It tends to strike older adults. The U.S. ... Read more

Related support groups: Herpes Zoster, Zostavax, Shingrix, Herpes Zoster Iridocyclitis, Herpes Zoster Peripheral Neuropathy, Herpes Zoster Meningitis, Herpes Zoster Myelitis

New Shingles Vaccine, Shingrix, Approved by FDA

Posted 25 Oct 2017 by Drugs.com

A new, more effective shingles vaccine has been approved by the U.S. Food and Drug Administration. The new vaccine from GlaxoSmithKline will be the second shingles vaccine available in the U.S. market. The other is from Merck and was introduced in 2006, the Associated Press reported. Shingles is a painful condition caused by the chickenpox virus. Anyone who's had chickenpox carries the virus that causes shingles. A study funded by Glaxo found that the company's Shingrix vaccine prevented shingles in about 90 percent of people. Merck's Zostavax vaccine is about 50 percent effective, the AP reported. Shingrix will cost $280 for the required two shots. Zostavax costs $223. Most insurance plans cover the vaccination. Both vaccines are for adults 50 and older, but the Centers for Disease Control and Prevention recommends vaccination for people 60 and older, partly because vaccination loses ... Read more

Related support groups: Herpes Zoster, Zostavax, Shingrix, Herpes Zoster Iridocyclitis, Herpes Zoster - Prophylaxis, Zoster Vaccine Live, Herpes Zoster Myelitis, Herpes Zoster Peripheral Neuropathy, Zoster Vaccine (recombinant), Herpes Zoster Meningitis

Our Gorilla Cousins Harbor Mono-Like Virus, Too

Posted 14 Jul 2017 by Drugs.com

FRIDAY, July 14, 2017 – Researchers say a herpes virus similar to the Epstein-Barr virus that infects people has been found in mountain gorillas. The discovery may assist in the conservation of critically endangered mountain gorillas, according to scientists at the University of California, Davis. The finding might also benefit people with the Epstein-Barr virus, they said. Epstein-Barr – also called human herpesvirus 4 – infects more than 90 percent of people worldwide, but typically causes no symptoms or serious health consequences. However, it can lead to certain types of cancer in people with HIV/AIDS and weakened immune systems. It's also one of the major causes of mononucleosis, often called the "kissing disease." The researchers analyzed saliva found on plants chewed by mountain gorillas in Rwanda and Uganda. They found the gorillas have their own version of this herpes virus. ... Read more

Related support groups: Herpes Zoster, Viral Infection, Diagnosis and Investigation

Is Shingles Tied to Heart, Stroke Risk?

Posted 4 Jul 2017 by Drugs.com

TUESDAY, July 4, 2017 – Shingles may be tied to an increased risk for heart disease, a new study suggests. About one-third of Americans will develop shingles in their lifetime. The painful skin rash can occur in anyone who's had chickenpox, and the risk increases with age. The new study looked at 2003-2013 medical records for more than 23,000 people in South Korea who had shingles. The researchers also reviewed data on a similar number of people without shingles. They found the shingles group had a 59 percent higher risk of heart attack and a 35 percent higher risk of stroke than the others. Stroke risk was highest among those under 40. The risks of both stroke and heart attack were highest the first year after the onset of shingles and decreased with time, according to the study. The results appear in a research letter published July 3 in the Journal of the American College of ... Read more

Related support groups: Ischemic Stroke, Heart Disease, Herpes Zoster, Prevention of Cardiovascular Disease, Ischemic Stroke - Prophylaxis, Cardiovascular Risk Reduction, Thromboembolic Stroke Prophylaxis, Varicella-Zoster, Varicella Virus Vaccine, Ischemic Heart Disease, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, ProQuad, Varicella-Zoster - Prophylaxis, Varivax

Shingles Vaccine Cuts Chronic Pain, Hospitalizations

Posted 17 Mar 2017 by Drugs.com

FRIDAY, March 17, 2017 – Vaccination greatly reduces the risk of serious complications from shingles, a new study finds. Shingles occurs when the same virus that causes chickenpox is reactivated later in life. Nearly one-third of people in the United States will develop shingles. The risk increases with age, researchers said. The new study showed the vaccine was 74 percent effective in preventing hospitalizations for shingles during the three years after vaccination. That number dropped to 55 percent effective after four or more years. The immunization was 57 percent effective for preventing lasting pain in the three years after vaccination. The rate dropped to 45 percent after four years, the researchers said. The findings were published recently in the journal Clinical Infectious Diseases. "The fact that we found relatively high effectiveness against serious outcomes, such as ... Read more

Related support groups: Herpes Zoster, Trigeminal Neuralgia, Zostavax, Varicella-Zoster, Zoster Vaccine Live, Vaccination and Prophlaxis, Herpes Zoster Peripheral Neuropathy, Varicella-Zoster - Prophylaxis

Got an Itch? Use These Tips for Relief -- and Don't Scratch

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – Itchy skin is a common problem, but there are several ways to find relief, a dermatologist says. "There are many reasons for itchy skin," Dr. Hassan Galadari said in an American Academy of Dermatology news release. "It could be the result of a skin condition, such as eczema, shingles, hives or psoriasis, or it could be a sign of a contagious disease, like scabies or ringworm." To relieve itchy skin, Galadari offers these tips: Apply a cold, wet cloth or ice pack to the itchy area for five to 10 minutes or until the itch subsides. Or take an oatmeal bath. Use skin moisturizers that contain no additives, fragrances or perfumes. Apply topical anesthetics that contain pramoxine. Apply cooling agents such as menthol or calamine, or refrigerate your moisturizer to help achieve this cooling effect. Avoid scratching. It will irritate your skin and could lead to ... Read more

Related support groups: Skin Rash, Herpes Zoster, Psoriasis, Eczema, Scabies, Plaque Psoriasis, Calamine, Varicella-Zoster, Pramoxine, Menthol, Calmoseptine, Anusol, Biofreeze, Tiger Balm, Analpram-HC, Hydrocortisone/Pramoxine, Terocin, Caladryl, Salonpas, Caladryl Clear

Experimental Shingles Vaccine Looks Quite Effective: Study

Posted 15 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 14, 2016 – An experimental vaccine against shingles may offer lasting protection for most older adults who receive it, a new clinical trial found. Shingles is a painful rash that's triggered by a reactivation of the virus that causes chickenpox. About one-third of Americans develop the disease at some point, according to the U.S. Centers for Disease Control and Prevention (CDC). There already is a vaccine against shingles, but its effectiveness is limited. The new study found that the experimental vaccine protected about 90 percent of adults age 70 and up. And the effects were still apparent four years later. By comparison, the existing vaccine, Zostavax, cuts the risk of shingles by about half. And immunity wanes within five years, according to the CDC. The study results were published in the Sept. 15 issue of the New England Journal of Medicine. Researchers called ... Read more

Related support groups: Herpes Zoster, Zostavax, Varicella-Zoster, Herpes Zoster - Prophylaxis, Zoster Vaccine Live, Vaccination and Prophlaxis, Varicella-Zoster - Prophylaxis

Chickenpox, Shingles Vaccines Linked to Rare Eye Inflammation

Posted 25 Jan 2016 by Drugs.com

MONDAY, Jan. 25, 2016 – The vaccine for chickenpox and shingles has been linked to inflammation of the eye's cornea, but the number of such cases is small, a new study says. "Keratitis, or inflammation of the clear layer on the front of the eye, is a vision issue that can cause serious complications or even permanent damage to your vision if left untreated," Dr. Frederick Fraunfelder, chair of the ophthalmology department and director of the University of Missouri Eye Institute, said in a university news release. Researchers found 20 cases of keratitis in children and adults that occurred within a month of receiving a chickenpox or shingles vaccine. Symptoms of the disorder developed within 24 days of vaccination among adults. In children, symptoms began within 14 days of vaccination, the researchers said. The researchers said there is a probable relationship between the vaccine and ... Read more

Related support groups: Eye Conditions, Herpes Zoster, Zostavax, Varicella-Zoster, Keratitis, Corneal Ulcer, Eye Redness/Itching, Varicella Virus Vaccine, Corneal Abrasion, Herpes Zoster Iridocyclitis, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, ProQuad, Vaccination and Prophlaxis, Zoster Vaccine Live, Visual Defect/Disturbance, Varicella-Zoster - Prophylaxis, Varivax

Asthma May Be Linked to Shingles Risk

Posted 31 Dec 2015 by Drugs.com

THURSDAY, Dec. 31, 2015 – People who suffer from asthma may be more likely to develop the painful skin condition known as shingles, a new study suggests. The finding builds on previous research that suggested a link between childhood asthma and shingles risk. "Asthma represents one of the five most burdensome chronic diseases in the U.S., affecting up to 17 percent of the population," said study author Dr. Young Juhn, a general academic pediatrician and asthma epidemiologist at the Mayo Clinic Children's Research Center in Rochester, Minn. "The effect of asthma on the risk of infection or immune dysfunction might very well go beyond the airways," Juhn said in a Mayo news release. The researchers analyzed the medical records of patients with suspected cases of shingles. They identified 371 people (average age 67) with the condition. Those patients were compared to 742 people who didn't ... Read more

Related support groups: Asthma, Herpes Zoster, Asthma - Maintenance, Asthma - Acute, Zostavax, Allergic Asthma, Herpes Zoster - Prophylaxis, Reversible Airways Disease - Maintenance, Reversible Airways Disease

Shingles Linked to Raised Heart Risks for Seniors, Study Finds

Posted 15 Dec 2015 by Drugs.com

TUESDAY, Dec. 15, 2015 – Seniors who develop the painful rash known as shingles appear to face a short-term increase in their risk for having a stroke or heart attack, new research indicates. The finding was based on the tracking of heart health among more than 67,000 newly diagnosed shingles patients who were aged 65 and older. The analysis revealed that stroke risk more than doubled in the first week following a shingles diagnosis, with heart attack risk also climbing, though not by quite as much. The risk for both appeared to return to normal within six months. "The study highlights when patients with shingles may be most vulnerable," explained study author Caroline Minassian, a research fellow in the faculty of epidemiology and population health at the London School of Hygiene & Tropical Medicine in England. "If we know when these events are more likely to happen, this may ... Read more

Related support groups: Heart Disease, Herpes Zoster, Zostavax, Cardiovascular Conditions and Disorders, Ischemic Heart Disease, Herpes Zoster Peripheral Neuropathy, Herpes Zoster Meningitis

Herpes Virus Tied to Angina Risk, Study Suggests

Posted 16 Jun 2015 by Drugs.com

TUESDAY, June 16, 2015 – There seems to be a higher risk of angina – chest pain related to clogged blood vessels – in the small number of people who have a type of herpes virus lurking in their genes, a new study suggests. Canadian researchers found that people with this inherited condition face three times the risk of angina as others. About 1 percent of people in the world appear to have this increased risk. There's no way to get rid of the genetic condition, because it is in a person's DNA, said study co-author Louis Flamand, vice chair of the department of microbiology-immunology at Laval University in Quebec, Canada. However, "as a preventive measure, subjects could be monitored more closely for the development of cardiovascular diseases," he said. "Considering that testing is simple, we propose that testing could be added to the list of genetic tests being performed on every ... Read more

Related support groups: Herpes Zoster, Angina, Herpes Simplex, Angina Pectoris Prophylaxis

Health Tip: Easing the Pain of Shingles

Posted 5 Mar 2015 by Drugs.com

-- Shingles is a viral infection that causes a painful, itchy, blistering rash. While the rash can occur anywhere on the body, most often it develops on the torso. Shingles develops among people who have had chickenpox. The chickenpox virus reactivates when the person gets older, emerging as shingles. The American Academy of Dermatology suggests these ways to ease shingles pain: Take a cool bath or apply a cool wet cloth or ice pack to the rash. Use calamine lotion on the blisters to ease itchiness. Use non-stick, sterile, loose bandages to cover the rash. Wear all-cotton, loosely-fitting clothing on areas that are particularly painful. Read more

Related support groups: Herpes Zoster

Shingles Vaccine Still Effective After Chemotherapy

Posted 8 Aug 2014 by Drugs.com

FRIDAY, Aug. 8, 2014 – The shingles vaccine remains effective in older people after they've had chemotherapy, a new study finds. "The zoster vaccine (Zostavax) has been shown to be safe and effective in elderly adults with healthy immune systems but until now, there has been a lack of data on whether the vaccine remains safe and effective for individuals who might have compromised immune systems resulting from treatments like chemotherapy," study author Hung Fu Tseng, of the Kaiser Permanente Southern California Department of Research and Evaluation, said in a Kaiser news release. "Our study demonstrates that older patients who had previously been vaccinated against shingles have a lower chance of developing this painful and often debilitating disease after chemotherapy," Tseng said. Researchers analyzed the medical records of more than 21,000 people aged 60 and older who had ... Read more

Related support groups: Herpes Zoster, Zostavax, Herpes Zoster - Prophylaxis, Zoster Vaccine Live

Stroke Risk Spikes Shortly After Shingles Episode: Study

Posted 3 Apr 2014 by Drugs.com

THURSDAY, April 3, 2014 – People with shingles face a significantly increased risk of stroke in the weeks following the first signs of the painful skin rash, new research suggests. Patients' overall stroke risk is highest in the first month after the onset of shingles, when they are 63 percent more likely to have a stroke, said study author Dr. Sinead Langan, a senior lecturer at the London School of Hygiene and Tropical Medicine. The risk tapers off during the following five months, she added. Shingles patients also have a threefold increased risk of stroke if they develop the rash around one or both eyes, according to the report published online April 3 in the journal Clinical Infectious Diseases. However, the study also delivered some good news for people with shingles, Langan added. "We found that the risk of stroke was lower in people who were treated with antiviral medications ... Read more

Related support groups: Ischemic Stroke, Herpes Zoster

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Varicella-Zoster, Herpes Zoster Otitis Externa, Herpes Zoster Peripheral Neuropathy, Herpes Zoster Iridocyclitis, Herpes Zoster Meningitis, Herpes Zoster Myelitis, Infections

Related Drug Support Groups

prednisone, Valtrex, acyclovir, valacyclovir, Zovirax, famciclovir, Famvir, Deltasone, Sterapred, view more... Liquid Pred, Sterapred DS, Meticorten, Orasone, Prednicen-M, Prednicot